nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftibuten—Aphasia—Capecitabine—colon cancer	0.0192	0.0192	CcSEcCtD
Ceftibuten—Rigors—Capecitabine—colon cancer	0.0152	0.0152	CcSEcCtD
Ceftibuten—Aphasia—Methotrexate—colon cancer	0.0143	0.0143	CcSEcCtD
Ceftibuten—Renal impairment—Irinotecan—colon cancer	0.0142	0.0142	CcSEcCtD
Ceftibuten—Dehydration—Vincristine—colon cancer	0.0129	0.0129	CcSEcCtD
Ceftibuten—Dehydration—Irinotecan—colon cancer	0.0125	0.0125	CcSEcCtD
Ceftibuten—Irritability—Fluorouracil—colon cancer	0.0123	0.0123	CcSEcCtD
Ceftibuten—Melaena—Capecitabine—colon cancer	0.0121	0.0121	CcSEcCtD
Ceftibuten—Candida infection—Capecitabine—colon cancer	0.0119	0.0119	CcSEcCtD
Ceftibuten—Pancytopenia—Vincristine—colon cancer	0.0114	0.0114	CcSEcCtD
Ceftibuten—Dysuria—Vincristine—colon cancer	0.0112	0.0112	CcSEcCtD
Ceftibuten—Neutropenia—Vincristine—colon cancer	0.0112	0.0112	CcSEcCtD
Ceftibuten—Neutropenia—Irinotecan—colon cancer	0.0109	0.0109	CcSEcCtD
Ceftibuten—Pancytopenia—Fluorouracil—colon cancer	0.0106	0.0106	CcSEcCtD
Ceftibuten—Renal failure—Irinotecan—colon cancer	0.0102	0.0102	CcSEcCtD
Ceftibuten—Jaundice—Irinotecan—colon cancer	0.0101	0.0101	CcSEcCtD
Ceftibuten—Haemolytic anaemia—Capecitabine—colon cancer	0.01	0.01	CcSEcCtD
Ceftibuten—Renal impairment—Capecitabine—colon cancer	0.00948	0.00948	CcSEcCtD
Ceftibuten—Haemoglobin—Irinotecan—colon cancer	0.00938	0.00938	CcSEcCtD
Ceftibuten—Haemorrhage—Irinotecan—colon cancer	0.00933	0.00933	CcSEcCtD
Ceftibuten—Agranulocytosis—Fluorouracil—colon cancer	0.00929	0.00929	CcSEcCtD
Ceftibuten—Vaginal inflammation—Methotrexate—colon cancer	0.00926	0.00926	CcSEcCtD
Ceftibuten—Melaena—Methotrexate—colon cancer	0.00904	0.00904	CcSEcCtD
Ceftibuten—Haemoglobin—Fluorouracil—colon cancer	0.00898	0.00898	CcSEcCtD
Ceftibuten—Haemorrhage—Fluorouracil—colon cancer	0.00894	0.00894	CcSEcCtD
Ceftibuten—Vaginal infection—Methotrexate—colon cancer	0.00874	0.00874	CcSEcCtD
Ceftibuten—Aplastic anaemia—Methotrexate—colon cancer	0.00869	0.00869	CcSEcCtD
Ceftibuten—Irritability—Capecitabine—colon cancer	0.00861	0.00861	CcSEcCtD
Ceftibuten—Dehydration—Capecitabine—colon cancer	0.00839	0.00839	CcSEcCtD
Ceftibuten—Chills—Irinotecan—colon cancer	0.00837	0.00837	CcSEcCtD
Ceftibuten—Toxic epidermal necrolysis—Capecitabine—colon cancer	0.00813	0.00813	CcSEcCtD
Ceftibuten—Flatulence—Irinotecan—colon cancer	0.008	0.008	CcSEcCtD
Ceftibuten—Agitation—Vincristine—colon cancer	0.00766	0.00766	CcSEcCtD
Ceftibuten—Pancytopenia—Capecitabine—colon cancer	0.00741	0.00741	CcSEcCtD
Ceftibuten—Neutropenia—Capecitabine—colon cancer	0.00729	0.00729	CcSEcCtD
Ceftibuten—Dysuria—Capecitabine—colon cancer	0.00729	0.00729	CcSEcCtD
Ceftibuten—Convulsion—Vincristine—colon cancer	0.00723	0.00723	CcSEcCtD
Ceftibuten—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.0069	0.0069	CcSEcCtD
Ceftibuten—Renal failure—Capecitabine—colon cancer	0.00684	0.00684	CcSEcCtD
Ceftibuten—Anaphylactic shock—Vincristine—colon cancer	0.00681	0.00681	CcSEcCtD
Ceftibuten—Jaundice—Capecitabine—colon cancer	0.00678	0.00678	CcSEcCtD
Ceftibuten—Convulsion—Fluorouracil—colon cancer	0.00674	0.00674	CcSEcCtD
Ceftibuten—Haematuria—Capecitabine—colon cancer	0.00663	0.00663	CcSEcCtD
Ceftibuten—Anaphylactic shock—Irinotecan—colon cancer	0.00663	0.00663	CcSEcCtD
Ceftibuten—Agranulocytosis—Capecitabine—colon cancer	0.00649	0.00649	CcSEcCtD
Ceftibuten—Anorexia—Vincristine—colon cancer	0.00649	0.00649	CcSEcCtD
Ceftibuten—Irritability—Methotrexate—colon cancer	0.00641	0.00641	CcSEcCtD
Ceftibuten—Anaphylactic shock—Fluorouracil—colon cancer	0.00635	0.00635	CcSEcCtD
Ceftibuten—Anorexia—Irinotecan—colon cancer	0.00632	0.00632	CcSEcCtD
Ceftibuten—Haemoglobin—Capecitabine—colon cancer	0.00628	0.00628	CcSEcCtD
Ceftibuten—Haemorrhage—Capecitabine—colon cancer	0.00624	0.00624	CcSEcCtD
Ceftibuten—Insomnia—Vincristine—colon cancer	0.00616	0.00616	CcSEcCtD
Ceftibuten—Paraesthesia—Vincristine—colon cancer	0.00611	0.00611	CcSEcCtD
Ceftibuten—Anorexia—Fluorouracil—colon cancer	0.00605	0.00605	CcSEcCtD
Ceftibuten—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.00605	0.00605	CcSEcCtD
Ceftibuten—Insomnia—Irinotecan—colon cancer	0.006	0.006	CcSEcCtD
Ceftibuten—Paraesthesia—Irinotecan—colon cancer	0.00595	0.00595	CcSEcCtD
Ceftibuten—Decreased appetite—Vincristine—colon cancer	0.00592	0.00592	CcSEcCtD
Ceftibuten—Dyspnoea—Irinotecan—colon cancer	0.00591	0.00591	CcSEcCtD
Ceftibuten—Erythema multiforme—Capecitabine—colon cancer	0.0059	0.0059	CcSEcCtD
Ceftibuten—Somnolence—Irinotecan—colon cancer	0.00589	0.00589	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Vincristine—colon cancer	0.00588	0.00588	CcSEcCtD
Ceftibuten—Fatigue—Vincristine—colon cancer	0.00587	0.00587	CcSEcCtD
Ceftibuten—Dyspepsia—Irinotecan—colon cancer	0.00583	0.00583	CcSEcCtD
Ceftibuten—Constipation—Vincristine—colon cancer	0.00582	0.00582	CcSEcCtD
Ceftibuten—Decreased appetite—Irinotecan—colon cancer	0.00576	0.00576	CcSEcCtD
Ceftibuten—Insomnia—Fluorouracil—colon cancer	0.00574	0.00574	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Irinotecan—colon cancer	0.00572	0.00572	CcSEcCtD
Ceftibuten—Fatigue—Irinotecan—colon cancer	0.00571	0.00571	CcSEcCtD
Ceftibuten—Paraesthesia—Fluorouracil—colon cancer	0.0057	0.0057	CcSEcCtD
Ceftibuten—Constipation—Irinotecan—colon cancer	0.00567	0.00567	CcSEcCtD
Ceftibuten—Dyspnoea—Fluorouracil—colon cancer	0.00566	0.00566	CcSEcCtD
Ceftibuten—Somnolence—Fluorouracil—colon cancer	0.00564	0.00564	CcSEcCtD
Ceftibuten—Chills—Capecitabine—colon cancer	0.0056	0.0056	CcSEcCtD
Ceftibuten—Dyspepsia—Fluorouracil—colon cancer	0.00559	0.00559	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Vincristine—colon cancer	0.00557	0.00557	CcSEcCtD
Ceftibuten—Decreased appetite—Fluorouracil—colon cancer	0.00552	0.00552	CcSEcCtD
Ceftibuten—Pancytopenia—Methotrexate—colon cancer	0.00552	0.00552	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00548	0.00548	CcSEcCtD
Ceftibuten—Dysuria—Methotrexate—colon cancer	0.00543	0.00543	CcSEcCtD
Ceftibuten—Neutropenia—Methotrexate—colon cancer	0.00543	0.00543	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Irinotecan—colon cancer	0.00542	0.00542	CcSEcCtD
Ceftibuten—Abdominal pain—Vincristine—colon cancer	0.00538	0.00538	CcSEcCtD
Ceftibuten—Body temperature increased—Vincristine—colon cancer	0.00538	0.00538	CcSEcCtD
Ceftibuten—Flatulence—Capecitabine—colon cancer	0.00536	0.00536	CcSEcCtD
Ceftibuten—Dysgeusia—Capecitabine—colon cancer	0.00532	0.00532	CcSEcCtD
Ceftibuten—Abdominal pain—Irinotecan—colon cancer	0.00524	0.00524	CcSEcCtD
Ceftibuten—Body temperature increased—Irinotecan—colon cancer	0.00524	0.00524	CcSEcCtD
Ceftibuten—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.00513	0.00513	CcSEcCtD
Ceftibuten—Renal failure—Methotrexate—colon cancer	0.00509	0.00509	CcSEcCtD
Ceftibuten—Urticaria—Fluorouracil—colon cancer	0.00504	0.00504	CcSEcCtD
Ceftibuten—Body temperature increased—Fluorouracil—colon cancer	0.00502	0.00502	CcSEcCtD
Ceftibuten—Hypersensitivity—Vincristine—colon cancer	0.00501	0.00501	CcSEcCtD
Ceftibuten—Haematuria—Methotrexate—colon cancer	0.00494	0.00494	CcSEcCtD
Ceftibuten—Hypersensitivity—Irinotecan—colon cancer	0.00488	0.00488	CcSEcCtD
Ceftibuten—Asthenia—Vincristine—colon cancer	0.00488	0.00488	CcSEcCtD
Ceftibuten—Agranulocytosis—Methotrexate—colon cancer	0.00483	0.00483	CcSEcCtD
Ceftibuten—Asthenia—Irinotecan—colon cancer	0.00476	0.00476	CcSEcCtD
Ceftibuten—Hypersensitivity—Fluorouracil—colon cancer	0.00468	0.00468	CcSEcCtD
Ceftibuten—Haemoglobin—Methotrexate—colon cancer	0.00467	0.00467	CcSEcCtD
Ceftibuten—Diarrhoea—Vincristine—colon cancer	0.00466	0.00466	CcSEcCtD
Ceftibuten—Haemorrhage—Methotrexate—colon cancer	0.00465	0.00465	CcSEcCtD
Ceftibuten—Diarrhoea—Irinotecan—colon cancer	0.00454	0.00454	CcSEcCtD
Ceftibuten—Dry mouth—Capecitabine—colon cancer	0.00453	0.00453	CcSEcCtD
Ceftibuten—Dizziness—Vincristine—colon cancer	0.0045	0.0045	CcSEcCtD
Ceftibuten—Pruritus—Fluorouracil—colon cancer	0.00449	0.00449	CcSEcCtD
Ceftibuten—Erythema multiforme—Methotrexate—colon cancer	0.0044	0.0044	CcSEcCtD
Ceftibuten—Dizziness—Irinotecan—colon cancer	0.00438	0.00438	CcSEcCtD
Ceftibuten—Diarrhoea—Fluorouracil—colon cancer	0.00434	0.00434	CcSEcCtD
Ceftibuten—Vomiting—Vincristine—colon cancer	0.00433	0.00433	CcSEcCtD
Ceftibuten—Rash—Vincristine—colon cancer	0.00429	0.00429	CcSEcCtD
Ceftibuten—Dermatitis—Vincristine—colon cancer	0.00429	0.00429	CcSEcCtD
Ceftibuten—Headache—Vincristine—colon cancer	0.00426	0.00426	CcSEcCtD
Ceftibuten—Anorexia—Capecitabine—colon cancer	0.00423	0.00423	CcSEcCtD
Ceftibuten—Vomiting—Irinotecan—colon cancer	0.00421	0.00421	CcSEcCtD
Ceftibuten—Dizziness—Fluorouracil—colon cancer	0.0042	0.0042	CcSEcCtD
Ceftibuten—Rash—Irinotecan—colon cancer	0.00418	0.00418	CcSEcCtD
Ceftibuten—Dermatitis—Irinotecan—colon cancer	0.00418	0.00418	CcSEcCtD
Ceftibuten—Chills—Methotrexate—colon cancer	0.00417	0.00417	CcSEcCtD
Ceftibuten—Headache—Irinotecan—colon cancer	0.00415	0.00415	CcSEcCtD
Ceftibuten—Nausea—Vincristine—colon cancer	0.00404	0.00404	CcSEcCtD
Ceftibuten—Vomiting—Fluorouracil—colon cancer	0.00404	0.00404	CcSEcCtD
Ceftibuten—Insomnia—Capecitabine—colon cancer	0.00401	0.00401	CcSEcCtD
Ceftibuten—Rash—Fluorouracil—colon cancer	0.004	0.004	CcSEcCtD
Ceftibuten—Dermatitis—Fluorouracil—colon cancer	0.004	0.004	CcSEcCtD
Ceftibuten—Paraesthesia—Capecitabine—colon cancer	0.00398	0.00398	CcSEcCtD
Ceftibuten—Headache—Fluorouracil—colon cancer	0.00398	0.00398	CcSEcCtD
Ceftibuten—Dysgeusia—Methotrexate—colon cancer	0.00396	0.00396	CcSEcCtD
Ceftibuten—Dyspnoea—Capecitabine—colon cancer	0.00396	0.00396	CcSEcCtD
Ceftibuten—Nausea—Irinotecan—colon cancer	0.00394	0.00394	CcSEcCtD
Ceftibuten—Dyspepsia—Capecitabine—colon cancer	0.00391	0.00391	CcSEcCtD
Ceftibuten—Decreased appetite—Capecitabine—colon cancer	0.00386	0.00386	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Capecitabine—colon cancer	0.00383	0.00383	CcSEcCtD
Ceftibuten—Fatigue—Capecitabine—colon cancer	0.00382	0.00382	CcSEcCtD
Ceftibuten—Constipation—Capecitabine—colon cancer	0.00379	0.00379	CcSEcCtD
Ceftibuten—Nausea—Fluorouracil—colon cancer	0.00377	0.00377	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Capecitabine—colon cancer	0.00363	0.00363	CcSEcCtD
Ceftibuten—Urticaria—Capecitabine—colon cancer	0.00352	0.00352	CcSEcCtD
Ceftibuten—Body temperature increased—Capecitabine—colon cancer	0.00351	0.00351	CcSEcCtD
Ceftibuten—Abdominal pain—Capecitabine—colon cancer	0.00351	0.00351	CcSEcCtD
Ceftibuten—Convulsion—Methotrexate—colon cancer	0.00351	0.00351	CcSEcCtD
Ceftibuten—Anaphylactic shock—Methotrexate—colon cancer	0.0033	0.0033	CcSEcCtD
Ceftibuten—Hypersensitivity—Capecitabine—colon cancer	0.00327	0.00327	CcSEcCtD
Ceftibuten—Asthenia—Capecitabine—colon cancer	0.00318	0.00318	CcSEcCtD
Ceftibuten—Anorexia—Methotrexate—colon cancer	0.00315	0.00315	CcSEcCtD
Ceftibuten—Pruritus—Capecitabine—colon cancer	0.00314	0.00314	CcSEcCtD
Ceftibuten—Diarrhoea—Capecitabine—colon cancer	0.00304	0.00304	CcSEcCtD
Ceftibuten—Insomnia—Methotrexate—colon cancer	0.00299	0.00299	CcSEcCtD
Ceftibuten—Paraesthesia—Methotrexate—colon cancer	0.00297	0.00297	CcSEcCtD
Ceftibuten—Dyspnoea—Methotrexate—colon cancer	0.00294	0.00294	CcSEcCtD
Ceftibuten—Somnolence—Methotrexate—colon cancer	0.00294	0.00294	CcSEcCtD
Ceftibuten—Dizziness—Capecitabine—colon cancer	0.00293	0.00293	CcSEcCtD
Ceftibuten—Dyspepsia—Methotrexate—colon cancer	0.00291	0.00291	CcSEcCtD
Ceftibuten—Decreased appetite—Methotrexate—colon cancer	0.00287	0.00287	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Methotrexate—colon cancer	0.00285	0.00285	CcSEcCtD
Ceftibuten—Fatigue—Methotrexate—colon cancer	0.00285	0.00285	CcSEcCtD
Ceftibuten—Vomiting—Capecitabine—colon cancer	0.00282	0.00282	CcSEcCtD
Ceftibuten—Rash—Capecitabine—colon cancer	0.0028	0.0028	CcSEcCtD
Ceftibuten—Dermatitis—Capecitabine—colon cancer	0.00279	0.00279	CcSEcCtD
Ceftibuten—Headache—Capecitabine—colon cancer	0.00278	0.00278	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Methotrexate—colon cancer	0.0027	0.0027	CcSEcCtD
Ceftibuten—Nausea—Capecitabine—colon cancer	0.00264	0.00264	CcSEcCtD
Ceftibuten—Urticaria—Methotrexate—colon cancer	0.00262	0.00262	CcSEcCtD
Ceftibuten—Abdominal pain—Methotrexate—colon cancer	0.00261	0.00261	CcSEcCtD
Ceftibuten—Body temperature increased—Methotrexate—colon cancer	0.00261	0.00261	CcSEcCtD
Ceftibuten—Hypersensitivity—Methotrexate—colon cancer	0.00243	0.00243	CcSEcCtD
Ceftibuten—Asthenia—Methotrexate—colon cancer	0.00237	0.00237	CcSEcCtD
Ceftibuten—Pruritus—Methotrexate—colon cancer	0.00234	0.00234	CcSEcCtD
Ceftibuten—Diarrhoea—Methotrexate—colon cancer	0.00226	0.00226	CcSEcCtD
Ceftibuten—Dizziness—Methotrexate—colon cancer	0.00218	0.00218	CcSEcCtD
Ceftibuten—Vomiting—Methotrexate—colon cancer	0.0021	0.0021	CcSEcCtD
Ceftibuten—Rash—Methotrexate—colon cancer	0.00208	0.00208	CcSEcCtD
Ceftibuten—Dermatitis—Methotrexate—colon cancer	0.00208	0.00208	CcSEcCtD
Ceftibuten—Headache—Methotrexate—colon cancer	0.00207	0.00207	CcSEcCtD
Ceftibuten—Nausea—Methotrexate—colon cancer	0.00196	0.00196	CcSEcCtD
